ONCY
Oncolytics Biotech·NASDAQ
--
--(--)
--
--(--)
4.41 / 10
Netural
Capital flow data indicate a strong, positive trend with a 7.65/10 score. Ratios show consistent inflows across block, small, large, and extra-large categories, with the exception of a slightly negative Medium trend. This robust fund inflow aligns with the overwhelmingly bullish analyst consensus—100% Strong Buy from a single research source—and supports the stock despite its technical and fundamental challenges. The positive sentiment and capital support create a favorable backdrop for potential price appreciation if fundamentals improve.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-17
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for ONCY?
- ONCY holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.41/10 (Netural).
